Decreased platelet count in patients receiving continuous veno-venous hemofiltration: A single-center retrospective study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Wu, Buyun ^a   Gong, Dehua ^a   Xu, Bin ^a   He, Qunpeng ^a   Liu, Zhihong ^a   Ji, Daxi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT RESPONSE; AGE; CHINA; HEMOFILTRATION; KAPLAN MEIER METHOD; PATHOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TIME;

AGE FACTORS; CHINA; FEMALE; HEMOFILTRATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PLATELET COUNT; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THROMBOCYTOPENIA; TIME FACTORS;

EID: 84901272173     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097286     Document Type: Article

References (27)

1. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM (2011) The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 139: 271-278.
2. Ronco C, Bonello M, Bordoni V, Ricci Z, D'Intini V, et al. (2004) Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 22: 164-174. (Pubitemid 38142302)
3. Tolwani A (2012) Continuous renal-replacement therapy for acute kidney injury. N Engl J Med 367: 2505-2514.
4. Finkel KW, Podoll AS (2009) Complications of continuous renal replacement therapy. Semin Dial 22: 155-159.
5. Daugirdas JT, Bernardo AA (2012) Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. Kidney Int 82: 147-157.
6. Mulder J, Tan HK, Bellomo R, Silvester W (2003) Platelet loss across the hemofilter during continuous hemofiltration. Int J Artif Organs 26: 906-912. (Pubitemid 37479450)
7. Ronco C, Tetta C, Lupi A, Galloni E, Bettini MC, et al. (1995) Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 23: 99-107.
8. Valente C, Soares M, Rocha E, Cardoso L, Maccariello E (2013) The evaluation of sequential platelet counts has prognostic value for acute kidney injury patients requiring dialysis in the intensive care setting. Clinics (Sao Paulo) 68: 803-808.
9. Palsson R, Niles JL (1999) Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55: 1991-1997. (Pubitemid 29197989)
10. KDIGO AKI Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter, Suppl 2: 1-138.
11. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
12. Kramer AA, Zimmerman JE (2007) Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited. Crit Care Med 35: 2052-2056. (Pubitemid 47326440)
13. Ben Hamida C, Lauzet JY, Rezaiguia-Delclaux S, Duvoux C, Cherqui D, et al. (2003) Effect of severe thrombocytopenia on patient outcome after liver transplantation. Intensive Care Med 29: 756-762. (Pubitemid 36609568)
14. Crowther MA, Cook DJ, Meade MO, Griffith LE, Guyatt GH, et al. (2005) Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 20: 348-353. (Pubitemid 41727593)
15. Livingston DH, Anjaria D, Wu J, Hauser CJ, Chang V, et al. (2003) Bone marrow failure following severe injury in humans. Ann Surg 238: 748-753. (Pubitemid 38182268)
16. Wattel E, Cambier N, Caulier MT, Sautiere D, Bauters F, et al. (1994) Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases. Br J Haematol 87: 205-208. (Pubitemid 24207024)
17. Li S, Li X, Li J, Deng X, Li Y (2007) Inhibition of oxidative-stress- induced platelet aggregation by androgen at physiological levels via its receptor is associated with the reduction of thromboxane A2 release from platelets. Steroids 72: 875-880. (Pubitemid 47410067)
18. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, et al. (2002) Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30: 1765-1771. (Pubitemid 34879588)
19. Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, de Lassence A, et al. (2007) Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest 131: 1735-1741. (Pubitemid 46981627)
20. Kiaii M, Djurdjev O, Farah M, Levin A, Jung B, et al. (2011) Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia. JAMA 306: 1679-1687.
21. Joannidis M, Oudemans-van Straaten HM (2007) Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care 11: 218.
22. Junqueira DR, Perini E, Penholati RR, Carvalho MG (2012) Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev 9: CD007557.
23. Alatri A, Armstrong AE, Greinacher A, Koster A, Kozek-Langenecker SA, et al. (2012) Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective. Thromb Res 129: 426-433.
24. Saugel B, Phillip V, Moessmer G, Schmid RM, Huber W (2010) Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study. Crit Care 14: R90.
25. Link A, Girndt M, Selejan S, Rbah R, Bohm M (2008) Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study. Crit Care 12: R111.
26. Post JB (2010) Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report. Am J Kidney Dis 55: e25-28.
27. Liu S, Shi W, Liang X, Su Y, Liang Y, et al. (2010) Cellulose triacetate dialyzer reduces platelet loss during continuous veno-venous hemofiltration. Blood Purif 29: 375-382.